LGALS3 and neoplasm: Additionally, not every ligand expressed on HEVs has the ability to substantially affect tumor-infiltrating CD8+ T cells; only Gal-9, MHC II, Gal-3, and PD-L1 play important roles in mediating CD8+ T cell subsets’ entry into the TLSs.